Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
46.24
-0.71 (-1.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,561,319
Open
46.49
Bid (Size)
46.40 (300)
Ask (Size)
47.00 (300)
Prev. Close
46.95
Today's Range
45.88 - 47.66
52wk Range
30.04 - 78.48
Shares Outstanding
78,935,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026
Today 10:13 EDT
As of March 20, 2026, Vertex Pharmaceuticals (NASDAQ: VRTX) has officially transcended its long-held identity as "the cystic fibrosis (CF) company." For over a decade, the Boston-based biotech giant...
Via
Finterra
Topics
Intellectual Property
Is CRISPR Therapeutics Stock a Buy Now?
↗
Today 8:20 EDT
We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.
Via
The Motley Fool
Performance
YTD
-14.0%
-14.0%
1 Month
-13.6%
-13.6%
3 Month
-17.2%
-17.2%
6 Month
-25.8%
-25.8%
1 Year
+12.3%
+12.3%
More News
Read More
3 Monster Stocks to Hold for the Next 10 Years
↗
March 10, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday
↗
March 10, 2026
Via
The Motley Fool
Why Is CRSP Stock Falling Pre-Market Today?
↗
March 10, 2026
Via
Stocktwits
RIVN Stock Gains 4% Pre-Market After TD Cowen Upgrade: Analyst Sees Strong Demand For Upcoming R2 Models
↗
March 10, 2026
Via
Stocktwits
Topics
Electric Vehicles
Forget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of
↗
March 04, 2026
Via
The Motley Fool
Is CRISPR Therapeutics Stock Too Risky to Buy Right Now?
↗
March 02, 2026
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
March 01, 2026
Via
The Motley Fool
Topics
ETFs
Is CRISPR Therapeutics Stock Going to $0, or Will the Hype Pay Off?
↗
February 20, 2026
Via
The Motley Fool
The Gene‑Therapy Breakthrough Story You'll Be Mad You Ignored at These Prices
↗
February 20, 2026
Via
The Motley Fool
Topics
ETFs
2 Innovative Biotech Stocks That May Climb 58% and 200%, According to Wall Street
↗
February 19, 2026
Via
The Motley Fool
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows
↗
February 19, 2026
Via
MarketBeat
Should You Buy Shares of CRISPR Therapeutics in February?
↗
February 18, 2026
Via
The Motley Fool
The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026
↗
February 13, 2026
Via
The Motley Fool
Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss)
↗
February 13, 2026
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
January 30, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Forget AI Stocks: This Biotech Could Cure What AI Can't Touch
↗
January 29, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Nasdaq, S&P 500 Futures Climb Ahead Of Apple Earnings: Why META, TSLA, MP, CRML, SER Are On Traders' Radar Today
↗
January 29, 2026
Via
Stocktwits
Topics
Artificial Intelligence
ETFs
Government
Cathie Wood's Favorite Biotech Stock Is Under Pressure Amid Insider Sales And Slow Revenue Growth: Momentum Score Drops
↗
January 27, 2026
Via
Benzinga
2 Biotech Stocks That Could Soar This Year
↗
January 12, 2026
Via
The Motley Fool
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
These 2 Healthcare Stocks Beat the Market in 2025. Should You Buy Them in 2026?
↗
December 26, 2025
Via
The Motley Fool
The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
December 24, 2025
Via
PredictStreet
Topics
Economy
Is CRISPR Therapeutics Stock Yesterday's News?
↗
December 24, 2025
Via
The Motley Fool
Frequently Asked Questions
Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 46.24
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 03/20/26 04:00 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 3.65B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.